Chromium Single Cell Multiome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

10x Genomics, Inc Share Price Target $58 50 , now 21 7% Upside Potential

10x Genomics, Inc. Share Price Target '$58.50', now 21.7% Upside Potential

Genomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain

10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Ben hindsonAndrewb singletonGenomics incNational institute on agingNational institute of neurological disordersSecurities exchangeIntramural research programIntramural centerExchange commissionCreate comprehensive single cell atlasRelated dementiasSingle cell multiomeChromium single cell multiomeChief scientific officerNational instituteNeurological disorders

10x Genomics, Inc - Consensus buy rating and 21 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 21.0% Upside Potential

Paylocity holding corporationGenomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

10x Genomics, Inc - Consensus buy rating and 71 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 71.0% Upside Potential

Genomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

10x Genomics, Inc - Consensus buy rating and 12 7% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 12.7% Upside Potential

Genomics incPaylocity holding corporationChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene